Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Yahoo/Benzinga
Wed, 06/11/25 - 11:29 am
Novo Nordisk
Deep Apple Therapeutics
R&D
weight loss
obesity
Nvidia announces massive new initiatives in pharma and clinical research
Forbes
Wed, 06/11/25 - 10:52 am
NVIDIA
artificial intelligence
Novo Nordisk
IQVIA
Novo Nordisk starts new CagriSema weightloss drug trial
Investing.com
Tue, 06/10/25 - 11:50 am
Novo Nordisk
CagriSema
clinical trials
obesity
weight loss
The biggest obesity deals of 2025 so far
Pharma Voice
Mon, 06/9/25 - 10:58 am
obesity
Roche
Carmot Therapeutics
Zealand Pharma
M&A
Novo Nordisk
United Laboratories International
Eli Lilly
Camurus
Medicare negotiations underway to lower prices for next batch of drugs
NPR
Wed, 06/4/25 - 10:42 pm
drug pricing
Medicare
Inflation Reduction Act
Novo Nordisk
Amgen
Wegovy use up 50% among US teens
Yahoo/Reuters
Tue, 06/3/25 - 11:12 am
Novo Nordisk
obesity
Wegovy
weight loss
teens
Regeneron's weight-loss drug combo helps preserve muscle in study
MSN/Reuters
Tue, 06/3/25 - 10:43 am
Regeneron
Novo Nordisk
Wegovy
trevogrumab
obesity
clinical trials
Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
BioPharma Dive
Wed, 05/28/25 - 10:58 pm
Veru
obesity
endobosarm
Novo Nordisk
Wegovy
clinical trials
GLP-1 prescriptions for weight loss soar, despite obstacles
BioPharma Dive
Wed, 05/28/25 - 10:58 am
obesity
weight loss
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
GLP-1 agonists
Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change
Pharma Voice
Tue, 05/27/25 - 11:10 am
Pharma CEOs
Novo Nordisk
JNJ
AbbVie
Merck
pharma industry
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Motley Fool
Thu, 05/22/25 - 11:40 am
Eli Lilly
Novo Nordisk
Zebound
Wegovy
obesity
weight loss
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
CNBC
Thu, 05/22/25 - 10:50 am
Cigna
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
insurers
As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings
Fierce Pharma
Wed, 05/21/25 - 11:53 am
Eli Lilly
Novo Nordisk
diabetes
obesity
innovation
IDEA Pharma
Noom is offering smaller doses of compounded Wegovy for weight loss
Quartz
Wed, 05/21/25 - 11:11 am
Noom
Wegovy
Novo Nordisk
telehealth
weight loss
Novo CEO to depart as obesity drugmaker’s challenges rise
BioPharma Dive
Fri, 05/16/25 - 11:47 am
Novo Nordisk
Pharma CEOs
Lars Jørgensen
Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug
Fierce Biotech
Thu, 05/15/25 - 10:57 am
Pathos AI
Novo Nordisk
Prelude Therapeutics
funding
solid tumors
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Fierce Biotech
Wed, 05/14/25 - 10:56 am
Novo Nordisk
obesity
Septerna
Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial
Investing.com
Sun, 05/11/25 - 10:06 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth
Fierce Pharma
Wed, 05/7/25 - 11:46 am
Novo Nordisk
Wegovy
earnings
Are pharma’s DTC platforms actually creating engagement with patients?
Medical Marketing and Media
Tue, 05/6/25 - 10:27 am
DTC
patients
patient engagement
Eli Lilly
LillyDirect
Pfizer
PfizerForAll
Novo Nordisk
NovoCare
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »